NCT04026347 (VAPOR) is a NA clinical trial of Vesair Balloon in Stress Urinary Incontinence, sponsored by Solace Therapeutics, Inc..

Who is sponsoring NCT04026347?

NCT04026347 is sponsored by Solace Therapeutics, Inc..

What drugs are being tested in NCT04026347?

Interventions in NCT04026347: Vesair Balloon, Sham balloon placement.

What condition does NCT04026347 study?

NCT04026347 studies Stress Urinary Incontinence.

Is NCT04026347 still recruiting?

NCT04026347 is currently terminated. Last updated 13 May 2022.

Last reviewed 2022-05-13 · How we verify

NCT04026347: VAPOR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vesair Clinical Trial

Terminated NA Last updated 13 May 2022

What this trial tests

NA trial testing Vesair Balloon in Stress Urinary Incontinence in 158 participants. Terminated before completion.

Timeline

1 February 2020

Primary endpoint
28 February 2022

15 April 2022

Quick facts

Lead sponsor	Solace Therapeutics, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	158
Start date	1 February 2020
Primary completion	28 February 2022
Estimated completion	15 April 2022
Sites	25 locations across United States

Drugs / interventions tested

Vesair Balloon
Sham balloon placement

Conditions studied

Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →

Sponsor

Solace Therapeutics, Inc.

Who can join

18 and older, female only, with Stress Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment of Stress Urinary Incontinence in post-menopausal women

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vesair Balloon

Trials testing the same drug.

NCT03794206 — Vesair Balloon Confirmatory Trial (VECTOR) · NA · terminated

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

NCT06706362 — Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) · Phase 4 · recruiting
NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
NCT06840093 — Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial · NA · recruiting
NCT06111209 — The Anabolic Effect of Testosterone on Pelvic Floor Muscles · Phase 2 · recruiting
NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting

Other Solace Therapeutics, Inc. trials

Trials by the same sponsor.

NCT03794206 — Vesair Balloon Confirmatory Trial (VECTOR) · NA · terminated
NCT03082118 — Vesair Continued Access Trial · NA · completed
NCT02210273 — Solace Stress Urinary inContinence Control Efficacy and Safety Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04026347 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Solace Therapeutics, Inc.
Last refreshed: 13 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing